|
Orthologous residues
|
|
Sam68 (human): A71‑p, Sam68 (mouse): T71‑p, Sam68 (rat): N71‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody, western blotting
|
|
Disease tissue studied:
lymphoma, T cell lymphoma
|
|
Relevant cell lines - cell types - tissues:
EL-4 (T lymphocyte)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
ERK2 (mouse)
|
modification site within consensus motif, pharmacological activator of upstream enzyme, phospho-motif antibody, pharmacological inhibitor of upstream enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
phorbol ester
|
|
|
|
increase
|
|
|
U0126
|
phorbol ester
|
|
|
inhibit treatment-induced increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
activation
|
|
Effect of modification (process):
translation, altered
|
|
Comments:
regulates splicing
|